Almapharma SRL
2.2 FTEAlmapharma reported total assets of 515,565 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Apr 2026), with 2.2 full-time equivalents.
The score of Almapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -17 % Total assets +16 % Headcount (avg FTE) +120 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Almapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,272 € | ||||
| Equity | 256,263 € | ||||
| Cash | 61,642 € | ||||
| EBITDA | 59,766 € | ||||
| Total assets | 515,565 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Apr 2026
- Year ended 31 Dec 2024filed on 19 Apr 2025
- Year ended 31 Dec 2023filed on 03 May 2024
- Year ended 31 Dec 2022filed on 03 Apr 2023
- Year ended 31 Dec 2021filed on 24 May 2022
Almapharma's financial analysis
- Solvency49.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Almapharma
Almapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0427.782.965
- VAT number
- BE0427782965
- Peppol
- Registered · 0208:0427782965 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Aug 1985
- Registered office
- 8660 De Panne
- Size
- Micro · 2.2 FTE
- Latest accounts
- 2025 · filed on 07 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Almapharma (SRL) has been based in De Panne since 1985, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 28,272 € and equity of 256,263 €; its revenue is not published. With 2.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 49.7%, above the median of its sector (44.2%).
Companies similar to Almapharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vanoverschelde Retail sale of pharmaceutical products Wingene · balance sheet 515,473 €
- Curepharma Retail sale of pharmaceutical products Antwerp · balance sheet 516,103 €
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
- La Pharmacie de Saintes Retail sale of pharmaceutical products Tubize · balance sheet 514,575 €
- Phaies Retail sale of pharmaceutical products Ham-sur-Heure-Nalinnes · balance sheet 516,859 €
- Onco-HEM Retail sale of pharmaceutical products Binche · balance sheet 511,591 €
- Milliemo Retail sale of pharmaceutical products Lochristi · balance sheet 519,776 €
- Pharmatheek Retail sale of pharmaceutical products Drogenbos · balance sheet 520,106 €
Frequently asked questions about Almapharma
What is the revenue of Almapharma?
Almapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Almapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0427782965 for Almapharma, if the company is VAT-registered. Its company number (CBE) is 0427.782.965.
Where is the registered office of Almapharma?
According to the CBE register, the registered office of Almapharma is in 8660 De Panne.
What is the equity of Almapharma?
At the close of the 2025 financial year, the equity of Almapharma amounts to 256,263 €, a solvency of 49.7% of total assets.
How many people work at Almapharma?
2.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Almapharma?
The register lists 2 active mandates at Almapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Almapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →